1. Home
  2. CREX vs ITRM Comparison

CREX vs ITRM Comparison

Compare CREX & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREX
  • ITRM
  • Stock Information
  • Founded
  • CREX N/A
  • ITRM 2015
  • Country
  • CREX United States
  • ITRM Ireland
  • Employees
  • CREX N/A
  • ITRM N/A
  • Industry
  • CREX EDP Services
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • CREX Technology
  • ITRM Health Care
  • Exchange
  • CREX Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • CREX 33.5M
  • ITRM 36.3M
  • IPO Year
  • CREX N/A
  • ITRM 2018
  • Fundamental
  • Price
  • CREX $3.36
  • ITRM $0.97
  • Analyst Decision
  • CREX Strong Buy
  • ITRM Strong Buy
  • Analyst Count
  • CREX 2
  • ITRM 2
  • Target Price
  • CREX $8.00
  • ITRM $7.00
  • AVG Volume (30 Days)
  • CREX 188.5K
  • ITRM 515.1K
  • Earning Date
  • CREX 05-14-2025
  • ITRM 05-13-2025
  • Dividend Yield
  • CREX N/A
  • ITRM N/A
  • EPS Growth
  • CREX N/A
  • ITRM N/A
  • EPS
  • CREX N/A
  • ITRM N/A
  • Revenue
  • CREX $48,303,000.00
  • ITRM N/A
  • Revenue This Year
  • CREX $10.03
  • ITRM N/A
  • Revenue Next Year
  • CREX $18.84
  • ITRM $108.39
  • P/E Ratio
  • CREX N/A
  • ITRM N/A
  • Revenue Growth
  • CREX 1.68
  • ITRM N/A
  • 52 Week Low
  • CREX $1.28
  • ITRM $0.81
  • 52 Week High
  • CREX $5.20
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • CREX 68.78
  • ITRM 45.57
  • Support Level
  • CREX $2.80
  • ITRM $0.93
  • Resistance Level
  • CREX $3.64
  • ITRM $1.05
  • Average True Range (ATR)
  • CREX 0.46
  • ITRM 0.05
  • MACD
  • CREX 0.05
  • ITRM 0.01
  • Stochastic Oscillator
  • CREX 72.40
  • ITRM 50.00

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: